Login / Signup

The effectiveness of the anti-tumor necrosis factor therapy infliximab in neuro-Behçet's disease: a systematic review and meta-analysis.

Reem Hamdy A MohammedYohannes W Woldeamanuel
Published in: The Journal of international medical research (2023)
Infliximab showed considerable therapeutic effectiveness in the treatment of refractory neuro-Behçet's disease.
Keyphrases
  • randomized controlled trial
  • systematic review
  • rheumatoid arthritis
  • stem cells
  • bone marrow
  • mesenchymal stem cells